Potential of phytase-mediated iron release from cereal-based foods: a quantitative view. by Nielsen, Anne Veller Friis et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Potential of phytase-mediated iron release from cereal-based foods: a quantitative
view.
Nielsen, Anne Veller Friis; Tetens, Inge; Meyer, Anne S.
Published in:
Nutrients
Link to article, DOI:
10.3390/nu5083074
Publication date:
2013
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Nielsen, A. V. F., Tetens, I., & Meyer, A. S. (2013). Potential of phytase-mediated iron release from cereal-based
foods: a quantitative view. Nutrients, 5(8), 3074-3098. DOI: 10.3390/nu5083074
Nutrients 2013, 5, 3074-3098; doi:10.3390/nu5083074 
 
nutrients 
ISSN 2072-6643 
www.mdpi.com/journal/nutrients 
Review 
Potential of Phytase-Mediated Iron Release from Cereal-Based 
Foods: A Quantitative View 
Anne V. F. Nielsen 
1
, Inge Tetens 
2
 and Anne S. Meyer 
1,
* 
1
 Center for BioProcess Engineering, Department of Chemical and Biochemical Engineering, 
Technical University of Denmark, 2800 Kgs. Lyngby, Denmark; E-Mail: avfn@kt.dtu.dk 
2 
Division of Nutrition, National Food Institute, Technical University of Denmark, 2860 Søborg, 
Denmark; E-Mail: intet@food.dtu.dk 
* Author to whom correspondence should be addressed; E-Mail: am@kt.dtu.dk;  
Tel.: +45-45-252-909; Fax: +45-45-932-906. 
Received: 12 April 2013; in revised form: 1 July 2013 / Accepted: 17 July 2013 /  
Published: 2 August 2013 
 
Abstract: The major part of iron present in plant foods such as cereals is largely 
unavailable for direct absorption in humans due to complexation with the negatively 
charged phosphate groups of phytate (myo-inositol (1,2,3,4,5,6)-hexakisphosphate).  
Human biology has not evolved an efficient mechanism to naturally release iron from iron 
phytate complexes. This narrative review will evaluate the quantitative significance of 
phytase-catalysed iron release from cereal foods. In vivo studies have shown how addition 
of microbially derived phytases to cereal-based foods has produced increased iron 
absorption via enzyme-catalysed dephosphorylation of phytate, indicating the potential of 
this strategy for preventing and treating iron deficiency anaemia. Despite the immense 
promise of this strategy and the prevalence of iron deficiency worldwide, the number of 
human studies elucidating the significance of phytase-mediated improvements in iron 
absorption and ultimately in iron status in particularly vulnerable groups is still low.  
A more detailed understanding of (1) the uptake mechanism for iron released from partially 
dephosphorylated phytate chelates, (2) the affinity of microbially derived phytases towards 
insoluble iron phytate complexes, and (3) the extent of phytate dephosphorylation required 
for iron release from inositol phosphates is warranted. Phytase-mediated iron release can 
improve iron absorption from plant foods. There is a need for development of innovative 
strategies to obtain better effects. 
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1. Introduction 
Iron deficiency anaemia is the most common nutrition deficiency disorder worldwide and a problem 
in both developed and developing countries. Low iron intakes and poor iron absorption from the diet 
are common causes of anaemia with women of the child-bearing age, pregnant mothers, adolescents 
and the elderly being particularly susceptible [1]. Uptake of non-haem iron from plant foods is lower 
than that of haem iron from meat products. The main inhibitor of non-haem iron absorption in plant 
foods is phytic acid (myo-inositol (1,2,3,4,5,6)-hexakisphosphoric acid). The phosphate groups of 
phytic acid are negatively charged under physiologically relevant conditions, resulting in phytate 
chelation of cations such as iron and zinc, making these minerals less available for absorption [2,3]. 
For vegetarians, elimination of meat coupled with high intakes of phytate-rich whole grains is known 
to lower iron absorption, increasing the risk of iron deficiency [4]. Analogously, consumption of the 
recommended daily intake of fibre-rich wheat bread has been found to impair iron status in young 
women with initially sufficient iron stores [5]. Phytases (mainly enzyme classes E.C. 3.1.3.8,  
E.C. 3.1.2.26) catalyse release of phosphate from phytate, in turn releasing the chelated minerals. 
Rather than relying on iron supplements or adding extra iron to foods, e.g., in the form of NaFeEDTA, 
phytase-catalysed dephosphorylation of naturally present iron phytate chelates in whole grain products 
is a potential option for increasing bioavailability of iron in the diet. This narrative review will 
examine the quantitative potential of phytase-catalysed iron release from plant-derived food 
components, with particular emphasis on the actions of the phytase catalysis in vivo. The text will 
mainly focus on the phytase-catalysed release of iron from phytate iron complexes present in cereal 
foods, since cereals and cereal-based meals represent the key plant based staple food type, in which 
phytate significantly retards or inhibits iron absorption. 
2. Dietary Iron Bioavailability 
Dietary iron generally exists in two forms: Haem iron and non-haem iron. Haem iron constitutes 
50%–60% of iron in animal foods, whereas in plant foods the iron is found in non-haem form 
exclusively [6]. The average bioavailability (defined as the percentage absorption of the total amount 
of iron in the food) of haem iron is ~15%–35% [7], whereas non-haem iron is much less bioavailable, 
typically corresponding to ~1%–22% iron absorption [8–11], with cereal-based foods such as porridge 
having an iron absorption as low as 2%–3% [12]. 
The low bioavailability of non-haem iron is related to the chemical context of the iron in food.  
Non-haem iron in plant foods exists in a wide variety of chemical forms, e.g., ferric citrate, ferrous 
gluconate, ferrous fumarate, ferric dextrans, iron carbonyl, ferritin, ferric phytate, ferrous sulfate, 
ferrous carbonate, ferric chloride and ferric EDTA [13]. In wheat, the primary storage form of iron has 
for a long time been believed to be water-soluble monoferric phytate, constituting ~60% of the wheat 
bran iron [14,15]. Although a more recent study on wheat grains suggests that most of the iron in 
wheat is located in ferritin deposits [16] (a storage protein that contains up to 4500 solid mineral iron 
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atoms per molecule [17]), the exact level of iron stored this way in wheat and perhaps, other cereals is 
not known at present. Ferritin iron seems to be readily bioavailable to humans, although the 
mechanism of absorption is still unclear [18,19]. 
Generally, iron in foods is in the oxidised ferric form (Fe
3+
), but if not adsorbed or bound to a 
storage protein, such as in haem iron or ferritin, the ferrous iron form (Fe
2+
) is considered to be the 
primary form absorbed by humans [13]. 
It is well established that complexing agents such as ascorbic acid, citric acid, other organic acids, 
as well as proteins (notably animal proteins from meat) and peptides enhance iron absorption [3,20–22]. 
Research conducted by García-Casal and co-workers suggests that also vitamin A and beta-carotene 
may enhance iron absorption [23,24]. On the other hand, phytate, tannins, phosphates, polyphenols and 
antacids inhibit iron absorption [25,26]. However, a fully validated algorithm for accurate prediction of 
iron bioavailability and absorption is not yet available [27], despite it being much needed, as well as 
for setting reference values for dietary iron intakes [28]. 
The absorption-enhancing effect of ascorbic acid is thought to be a result of the reducing properties 
of ascorbic acid, which reduce the less soluble Fe
3+
 ion to Fe
2+
 iron. Apart from being more readily 
absorbed, the Fe
2+
 form is also less prone to form complexes with polyphenols or phytate [29]. This 
redox theory is corroborated by the presence of a putative binding site for ascorbate on duodenal 
cytochrome-b (Dcyt-b, see Section 5 below on non-haem iron absorption), which catalyses the 
reduction of Fe
3+
 to Fe
2+
 prior to iron transport into the enterocyte [30]. Finally, ascorbic acid acts as a 
solubiliser, keeping iron in solution in the small intestine, thus enhancing absorption [31] and thereby, 
further preventing formation of the less soluble ferric phytate complexes [3]. 
Despite the findings that significant amounts of iron in wheat may be found in ferritin deposits [16], 
it is widely recognised that phytate is the major inhibitor of iron absorption from plant foods, notably 
in cereal-based diets [3,5,32–34]. It is not clear whether ferritin iron absorption is also inhibited by 
phytate, but available data suggests that the influence of phytate on ferritin iron absorption depends on 
the extent of ferritin degradation [35,36]. 
It has also been disputed to what extent iron status has an influence on how well haem and  
non-haem iron are absorbed, respectively, but the current consensus is that haem iron absorption is less 
affected than non-haem iron by iron status [29]. In any case, it is relevant to consider removal or 
degradation of phytate, i.e., iron phytate complexes, as a means to improve iron absorption in  
iron-deficient individuals, particularly in those consuming high amounts of whole grain cereals. 
3. Function, Structure and Properties of Phytic Acid 
Phytic acid (or phytate in the charged form) or myo-inositol (1,2,3,4,5,6)-hexakisphosphate  
(Figure 1) is the phosphorous storage compound in plants, where it accounts for 60%–90% of the seed 
phosphorous [3,37]. 
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Figure 1. Structure of monoferric phytate, where Fe
3+
 is chelated via its six coordination 
sites. Adapted from [3]. 
  
During seed development, phytic acid is deposited as mixed phytate salts of potassium, magnesium, 
calcium, zinc and iron [38] in globoids; hence, several different cations may be associated with each 
phytate molecule. Around ~80% [3] of the globoids are localised in the aleurone layer of most cereal 
grains, e.g., wheat and barley, whereas in, for example, maize, the globoids are found in the  
embryo [2,39]. Wheat phytate globoids have been found to be constituted of proteins (46% w/w),  
phytic acid (40% w/w) and minerals in a concentration order of K (7.6% w/w) > Mg (3.2% w/w) >  
Ca (0.43% w/w) > Fe (0.059% w/w) [40]. At seed maturity, ~15%–20% of the iron in the grain is 
localised in the pericarp, ~70% in the endosperm and aleurone layer and 7%–8% in the embryo [41]. 
At physiologically relevant pH values (pH ~1.5–7), phytic acid is negatively charged, accounting 
for the ability of phytate to chelate mineral cations. The more phosphorylated the inositol rings, the 
stronger the interaction with iron and the lower the solubility. At physiological conditions, i.e., in the 
intestinal environment, phytate thus forms complexes with ferric iron to form monoferric phytate 
(Figure 1). The pKa values of the phosphate protons corresponding to the carbon numbering in  
Figure 1 are as follows: C1 + C3: 1.5 and 12.0, C2: 1.1 and 6.85, C4 + C6: 2.1 and 10.0, C5: 1.7 and 
7.6 [42]. 
Monoferric phytate, which is the primary form of iron phytate, is water-soluble, but tetraferric 
phytate, i.e., phytate chelating four Fe
3+
 ions is not, indicating that differences in bioavailability of iron 
from iron phytate complexes may be dependent on solubility of the different stoichiometric versions of 
iron phytate complexes [15]. 
Phytate is found in relatively high amounts in plant foods, particularly in cereals and legumes [3]. 
Daily intake of phytic acid varies largely according to diet from ~0.2–4.6 g globally, with, e.g., 
vegetarian diets generally containing higher amounts of phytic acid compared to mixed diets [3,43]. 
Reported values for iron and phytic acid content in various cereal foods vary widely, but typical 
values for phytic acid content are in the range of 0.5%–1% by weight (e.g., [3,43,44]) (Table 1). The 
wide range of phytic acid levels is related to methodology of phytic acid determination, plant variety 
and origin as well as how the plants have been cultivated [3]. Apart from influencing the phytic acid 
content, differences in growing conditions can also affect the iron content as well as the distribution of 
iron between phytate and ferritin in plants [13] and may thus significantly influence iron 
bioavailability of plant foods. 
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Table 1. Iron [45] and phytic acid (PA) content [43] in common cereal foods. 
Food 
Phytic acid 
(g/100 g) 
Iron content 
(mg/100 g) 
1
 
Estimated 
2
 
molar ratio PA:Fe 
Oatmeal 0.80–1.03 3.9 17–22 
White bread 0.28–1.00 1.0 24–85 
Whole grain bread 0.43–1.05 1.4 26–64 
Rye bread (whole meal) 0.03–0.41 1.5 2–23 
Rice 0.06–2.20 1.2 4–155 
1 The iron contents represent mean values and were not measured in the same products as the phytic acid;  
2 Rough estimates; calculated from a molar mass of phytic acid of 660 g/mol. 
4. Iron Intake and Requirements 
The iron contents of various cereal foods range from ~0.3–4 mg/100 g, with iron values in 
commonly consumed cereal foods ranging from ~1–4 mg/100 g (Table 1). For comparison, red meat 
contains ~0.2–2 mg iron per 100 g, but some meat products, e.g., liver, are very rich in iron, containing 
up to 31 mg iron per 100 g [45]. In order to fulfil the physiological requirements, approximately  
1–2 mg iron must be absorbed per day depending on gender and age, with menstruating women and 
children requiring more iron than other population groups [46]. In common western diets, an average 
of around 10 mg ferric non-haem and 2 mg haem iron is consumed daily [25]. These levels match the 
recommended intakes for boys and men, that according to the Nordic Nutrition Recommendations, are 
11 mg/day for boys aged 14–17, and 9 mg iron/day for men aged 18 and older [47]. However, for 
women of the childbearing age and lactating women, the recommendation for iron intake is 15 mg/day, 
with further recommendations on iron supplements during the second and third trimester for pregnant 
women [47], indicating that the iron requirements may not be met through the habitual diet. 
5. Non-Haem Iron Absorption in Humans 
Several factors determine the iron absorption from a meal: The amount and type of iron in the meal, 
the physiological mechanisms regulating iron absorption (uptake in intestinal cells and further transit) 
and the availability of the iron for uptake by the cellular transporters in the small intestine [48]. The 
iron status of the individual is another important determinant for iron absorption. Iron balance is 
maintained primarily by the iron-regulatory hormone hepcidin, which inhibits intestinal iron 
absorption and cellular iron release [25]. Hepcidin levels are upregulated by iron overload and 
inflammation, and downregulated by hypoxia and upon increased need for iron for erythropoiesis [25]. 
For the mechanism of absorption, haem iron is readily absorbed in the intestinal system by  
receptor-mediated endocytosis or direct haem transporters, although the detailed mechanisms are not 
fully elucidated [49]. 
More details are known regarding the mechanism for non-haem iron absorption. Non-haem iron is 
absorbed in the proximal part of the duodenum after reduction of Fe
3+
 (which is the more common 
oxidation state of iron in food) to Fe
2+
 by action of a ferrireductase, presumably duodenal  
cytochrome-b (Dcytb), present in the apical brush border of the intestinal wall [25,49]. A binding site 
for ascorbate on this enzyme underlines the role of ascorbic acid as an electron donor for Fe
3+
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reduction [30]. Fe
2+
 ions are then transported into the enterocyte using the divalent metal transporter-1 
(DMT-1), which is also located in the apical brush border. This transport reaction is proton-driven, 
indicating that an acidic environment (optimal pH 5.5–5.8) is required for iron absorption, underlining 
that the primary site of iron absorption is just distal to the pylorus, where pH is still relatively low [25]. 
Expression of DMT-1 is induced in iron-deficient individuals [25]. Iron in the enterocytes can be 
retained or shuttled out of the cell, but the further fate of absorbed iron will not be considered  
in this review. 
There is a surprising scarcity of data unravelling the details concerning the mechanism of cellular 
uptake of iron complexed to phytate and/or lower inositol phosphates (i.e., inositols with  
≤5 phosphates), but iron complexed with phytate is probably not directly bioavailable for entering the 
pathway for iron absorption described above. The currently available evidence is thus weak or  
non-existent, but a plausible scenario is that absorption of iron bound in iron phytate complexes into 
the enterocytes from the duodenum lumen can only occur after the iron has been released from the 
phytate, and reduced from the Fe
3+
 to the Fe
2+
 form. It remains to be elucidated, whether and how Fe
3+
 
more loosely chelated to inositol phosphates is absorbed. Competition between ascorbic acid and 
phytate as iron chelators may play a role [3], as the ascorbic acid-iron complex is presumably available  
for absorption. 
6. Chemical Form of Iron Phytate Complexes in the Gastrointestinal System 
The chemical form of the phytate in the gut is an important parameter for the assessment of  
non-haem iron bioavailability in the gut. Phytate shows increasing chelating affinity, i.e., lower 
dissociation constant, from mono- to multivalent cations [3]. However, factors such as competing 
chelating agents should also be taken into consideration when evaluating the iron phytate interactions 
in the gut. 
As previously mentioned, the pKa values of the phytate phosphates result in phytate being 
negatively charged at physiologically relevant pH values, i.e., pH values lower than ~1 are necessary 
for phytic acid to be in the fully protonated form. After a meal, pH in the stomach is typically ~3–7, 
decreasing gradually over a few hours to the fasting pH ~2 [50–52]. Assuming that the pKa values are 
independent of iron binding, phytate will thus carry six negative charges in the gastric ventricle  
(pH range ~3–7). 
It has recently been experimentally confirmed that the iron phytate complex will be primarily in the 
associated monoferric form in the pH range above ~4, with Fe
3+
 existing as free ferric ions or ferric 
hydroxides at lower pH values [53]. The predominating forms between pH 3 and 7 are tri-, di-, mono- 
and non-protonated monoferric phytate with non-protonated monoferric phytate being the prevailing 
form at pH values exceeding ~5.8 [53] (Figure 1). 
Studies on the sequestering ability of phytate have shown that the relative affinity of phytate 
towards different metal cations depends on pH, meaning that for example at pH ~6–8, Fe3+ is chelated 
more strongly than Cr
3+
 and Al
3+
 ions, whereas iron is the least strongly chelated of the three metal 
species at pH values below ~6 [53]. Furthermore, the concentration of phytate at which 50% of iron 
present in trace amounts is chelated has been found to range from 4.7 × 10
−6
 M to 1.1 × 10
−10
 M from 
pH 4.0–7.4 [53]. Hence, if, for example, 60 g oatmeal (containing, e.g., 0.9 g phytic acid/100 g,  
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see Table 1) is consumed with milk resulting in a total volume of the gastric ventricle after intake of 
~0.5 L, the potential concentration of phytate in the stomach is ~1 mM, thus at least 1000-fold higher 
than the concentration necessary to sequester 50% of the iron ions. Ismail-Beigi et al. [54] found that 
wheat bran binds 72% of iron (0.5 mg/L) in vitro at pH 6.5–6.8 (duodenal pH range), which 
corroborates that most iron is associated with phytate in the pH conditions of the human 
gastrointestinal system. 
Furthermore, it has been proposed that inositol triphosphate (myo-inositol phosphorylated on C1, 
C2 and C3) quantitatively chelates Fe
3+
 in a 1:1 ratio at physiologically relevant pH values (including 
acidic environments) [55]. Another study has shown that complexation of phytate with Fe
3+
 causes 
acidification, meaning that phytate is further deprotonated upon association with Fe
3+
 and that at 
Fe
3+
:phytate ratios higher than ~4, intermolecular interactions will occur, forming a network of ferric 
phytates causing precipitation of aggregates [56]. 
As earlier mentioned, phytate in the plants naturally exists as mixed salts of several different 
mineral cations. It can therefore be speculated that under physiological conditions in the 
gastrointestinal system, the phytate molecule will still be associated with several different cations as 
well as the iron, although no exact information could be found on this matter. 
7. Degradation of Phytate in the Human Gastrointestinal System 
Very few studies have been conducted on the hydrolysis of phytate, notably iron phytate complexes 
and phytate globoids, in the human gastrointestinal system, including the hydrolysis of phytate in the 
stomach [57]. Early studies showed only limited degradation, i.e., dephosphorylation, of phytate in the 
human gastrointestinal system as measured by recovery of ~40%–70% phytate in faeces [58,59]. 
Human ileostomy studies conducted by Sandberg’s group [60–62] showed that 95% ± 10% of 
phytate initially present in the diet was recovered after passage of an extruded wheat bran diet through 
the stomach and small intestine with no detection of lower inositol phosphates, whereas 42% ± 12% of 
the phytate was recovered in an unprocessed wheat bran diet and with detectable amounts of inositol 
penta-, tetra- and triphosphates in the ileostomy content [62]. They also found that the absorption of 
Zn, Mg and P was significantly decreased from the extruded product, whereas absorption of Ca and Fe 
was at the same level for the two products, indicating that phytate needs to be dephosphorylated to a 
higher extent for Fe and Ca release to occur compared to Zn, Mg and P. 
It was later shown that very low phytase enzyme activity (see Section 8 on phytases below) is 
present in the human small intestine [63], so degradation of phytate in the gastrointestinal system is 
most likely ascribable to the presence of dietary phytase enzyme (endogenous to wheat) [64], although 
it has later been suggested that after the initiation of phytate dephosphorylation by endogenous food 
phytases, intestinal phosphatase enzymes may play a role in continuing the dephosphorylation [57]. 
As iron is absorbed in the small intestine, phytate hydrolysis occurring after this point in the 
intestinal system is not relevant with regard to increasing iron absorption. Therefore, phytate 
hydrolysis in the large intestine is not considered in the present review. 
In conclusion, natural degradation of phytate in the human gastrointestinal system is insufficient 
with regard to the release of absorbable iron from iron phytate complexes. One strategy that has been 
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suggested to alleviate this problem is the use of exogenous phytase enzymes, catalysing the 
dephosphorylation of phytate, in food processing and during in vivo digestion. 
8. Phytases 
Phytases are a subgroup of phosphorolytic enzymes that are capable of initiating (and continuing) 
the hydrolysis of phosphate groups from phytate. Phytases are used widely in feed for non-ruminant 
animals [65] and are classified according to their catalytic mechanism (histidine acid phytases,  
β-propeller phytases, cysteine phytases and purple acid phytases), pH optima (acid or alkaline 
phytases) and site of phytate hydrolysis initiation (3-phytases, E.C. 3.1.3.8; 6-phytases, E.C.3.1.3.26 
and 5-phytases, E.C.3.1.3.72) [66]. 
Most commercially available feed phytases are of fungal (Aspergillus niger) or bacterial 
(Escherichia coli) origin; they include both 3- and 6-phytase type histidine acid phytases and have a 
molecular weight of ~45–50 kDa, pH optima range within ~2.0–5.5 and temperature optima at  
~50–60 °C [65]. Many others have reviewed the properties, reaction mechanisms and production of 
different phytases, see, e.g., [2,65–70]. 
The World Health Organization has recently evaluated the 3-phytase from Aspergillus niger for use 
in and with food for humans and found it safe for consumption with an acceptable daily intake ―not 
specified‖ [71]. It remains to be seen whether other phytases that are used for animal feeds will be 
recognised as safe for human consumption. 
On this note, a patent for an iron fortification nutritional blend containing phytase has recently been 
granted to DSM, corroborating the industrial potential and actuality of these enzymes for defying iron 
deficiency in humans [72]. 
9. Degradation of Iron Phytate Complexes in the Gastrointestinal System 
9.1. Activity of Phytases in the Gastrointestinal System 
The gastrointestinal system constitutes a hostile environment for most enzymes, particularly due to 
the low pH in the stomach and the presence of proteolytic enzymes, notably pepsin in the stomach and 
trypsin and chymotrypsin in the small intestine. 
It has been shown that endogenous wheat phytases are mostly active in the gastric ventricle, where 
they retain ~9% of their activity (compared to the activity in the feed of 43 mU/mg protein), whereas 
in the small intestine activity retention is only ~2%; in practice meaning that wheat phytase-catalysed 
phytate degradation takes place in the stomach only [73]. 
The enzyme inactivation is caused by proteolysis by pepsin in the pylorus and unfavourable pH 
conditions in the duodenal chyme (pH 6.5–7), as wheat phytase has a pH optimum of 5.5 and 6.0 [40]. 
For comparison, A. niger phytase is expected to retain 50%–60% activity in the stomach [74] and 
has optimum activity at pH 2.0 and 6.0 at 37 °C with activity in the entire range from pH 1.0–7.5 [75]. 
In one study, A. niger phytase has been found to continue phytate degradation in the  
duodenum [76]. Another study reported that A. niger phytase retained 95% activity after incubation at 
pH 3.5 with 5 mg pepsin/mL compared to only 70% activity retention for the wheat phytase [77].  
E. coli phytase has been found to exhibit an even higher stability in an acidic proteolytic (pepsin) 
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environment compared to the A. niger phytase, whereas A. niger phytase has been reported to be more 
stable than E. coli phytase when incubated with trypsin at pH 7.5 [68]. On a final stability note, fungal 
phytases generally have higher thermal stability than bacterial phytases [65]. 
9.2. Role of Exogenous Phytases in Gastrointestinal Phytate Degradation 
Supplementation of exogenous A. niger phytase to a wheat-based meal can improve iron absorption 
compared to endogenous wheat phytases by degradation of phytate in the gastrointestinal system [75]. 
Unfortunately, data from human studies regarding the details and mechanism of degradation of phytate 
(notably iron phytate and phytate globoids) in the gastrointestinal system using exogenous phytases are 
not available. However, an in vivo study in pigs has shown that endogenous feed phytases as well as 
added A. niger phytase (1800 FTU/kg feed) can catalyse the hydrolysis of phytate. This hydrolysis 
seems to be dependent on the extent of phytate solubility in the stomach (which was ~2/3) [73], as 
higher dosage of exogenous phytases did not increase phytate degradation. This indicates that 
solubility rather than catalytic activity limited phytate degradation. However, degradation of phytate to 
lower inositol phosphates increases their solubility [73] and susceptibility towards further degradation 
and lowers their affinity for mineral chelation [3,78]. 
Due to the pH increase, solubility of the inositol phosphates decreases as the food chyme is passed 
on to the duodenum, with lower inositol phosphates still exhibiting higher solubility than more 
phosphorylated inositols [3,73]. As the higher inositol phosphates have a higher tendency towards 
mineral chelation, the result is co-precipitation of mineral ions, e.g., Fe, Zn and Ca, thus making them 
unavailable for absorption [3]. On the other hand, the lower inositol phosphates, notably inositol  
di- and triphosphates, seem to keep the minerals in solution in the small intestine and potentially aid in 
the absorption of minerals in the small intestine [3]. 
Further hydrolysis in the duodenum is limited by the low solubility of the iron inositol phosphate 
complexes [73] as well as the acidic pH optima of most of the available microbial phytases that are 
under consideration for this application. Low substrate solubility in the small intestine is the main 
reason why the gastric ventricle is considered the primary target site for action of exogenous phytases 
for both phosphate (particularly relevant in animal nutrition) and iron release from iron  
phytate complexes. 
9.3. Extent of Phytate Degradation and Iron Absorption 
Having phytate partly dephosphorylated, the question is to which extent dephosphorylation is 
required to release iron for absorption. In an early study, lower inositol phosphates, notably inositol 
hexa- to tri-phosphates, were found to impair iron absorption proportionally to the degree of 
phosphorylation [79]. In a subsequent study conducted by the same group it was found that inositol 
hexa- and pentaphosphates inhibit iron absorption, whereas inositol tetra- and triphosphates alone do 
not inhibit iron absorption due to lower affinity for Fe
3+
 chelation [80]. However, the inositol  
tetra- and triphosphates were found to interact with higher inositol phosphates in inhibiting iron 
absorption and thus, it was concluded that at least four phosphates should be hydrolysed from phytate 
in order to significantly improve iron absorption from cereals and legumes. 
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Quantitatively, Yu and co-workers found that, compared to inositol hexaphosphate, the inositol 
pentaphosphates had a chelating power of ~70%–76%, inositol tetraphosphates ~35% and inositol 
triphosphates ~30%, whereas inositol di- and monophosphates exhibited no chelating power towards 
Fe
3+
 at pH 2.4 [78]. The stoichiometry of the detected iron phytate complex under these conditions was 
2:1 [78]. 
In order to significantly improve iron bioavailability, complete degradation of phytate is therefore 
recommended [12,57]. Complete phytate degradation, i.e., complete dephosphorylation, is expected to 
increase iron absorption five-fold or more [12] (up to 12-fold [34]), whereas a ~90% degradation 
would cause only a two-fold increase in iron absorption [12]. Lower degrees of hydrolysis are not 
expected to be useful with regard to iron absorption, since the iron will still be bound to phytate or 
lower inositol phosphates, but if complete dephosphorylation of phytate cannot be achieved, it is 
advised to keep the molar phytate:iron ratio below ~1:1, preferably below ~0.4:1, in order to limit the 
phytate chelation of iron that renders the iron unavailable for absorption [34]. 
10. Potential of Phytase-Mediated Iron Release from Plant Foods 
When assessing the potential of phytase-mediated iron release from plant foods in human studies, 
several issues need to be considered, e.g., iron status of the individuals in the study; dietary factors 
including, but not limited to, phytate content; how iron status can be assessed (which parameters are 
more suitable for evaluation and how informative in vitro studies can be conducted); where the phytate 
hydrolysis should take place (e.g., prior to ingestion or during digestion); to which extent the phytate 
should be dephosphorylated to significantly release iron; in which form released iron is present and the 
bioavailability of this iron form. 
When considering in vivo phytase catalysis, a range of questions arises regarding where in the 
gastrointestinal system and to what extent the phytase is active, what the form of the substrate (soluble, 
insoluble/aggregated, dissociated or complexed with minerals, degree of protonation) is at the site of 
catalysis and the affinity of the phytase for this form of phytate. It has, for instance, been shown by  
Tang et al. [81] that if phytate is present as precipitated phytate salts (e.g., ferric phytate) at pH 6, 
phytases from neither wheat Aspergillus ficuum nor Bacillus subtilis are able to catalyse the 
dephosphorylation of phytate. On the other hand, Bohn et al. [40] found that wheat phytase was active 
on phytate globoids at pH 6, indicating that the natural form of the phytate is accessible for degradation. 
When phytate is degraded ex vivo prior to ingestion of the food, the process can be monitored more 
easily and more reproducible and predictable results are likely to be obtained. 
With regard to the released iron, whether it is released prior to or after consumption, it is relevant to 
know its chemical form and biological availability. 
10.1. Effect of Evaluation Parameters in in Vitro Studies 
Generally, three parameters are most often assessed when results from in vitro/ex vivo studies  
are reported: 
1 Extent of phytate degradation and content of lower inositol phosphates; 
2 Dialysability of iron; 
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3 Cellular availability and/or uptake of iron. 
Of these, the last is the pertinent health parameter and the question is therefore to what extent the 
cellular availability and uptake of iron is explained by the other parameters, which are usually easier  
to evaluate. 
10.1.1. Phytate Degradation 
Phytate degradation is one of the most reported parameters, and possibly the least relevant of the 
three. In assessing reported results on phytate degradation, it is important to consider the method of 
phytate determination as different methods will report different results. Two methods exploiting the 
interaction of ferric iron with inositol phosphates are used, either for precipitation of ferric phytate 
(originally developed by Heubner and Stadler [82]) or as interactions resulting in soluble complexes as 
is the case with Wade’s reagent (ferric chloride and sulfosalicylic acid) [83]. These are relatively  
non-specific for phytate, as lower inositol phosphates are also able to participate in these interactions. 
Confirming this, Sandberg and co-workers concluded that the iron precipitation method was not 
suitable for evaluating phytate degradation [62]. Instead, various chromatographic separations can be 
performed to separate phytate from lower (i.e., less phosphorylated) inositol phosphates and thus give 
a better picture of the degree of dephosphorylation (e.g., [84]). Due to the significantly different 
outcome resulting from the use of different methods, some of the quantitative comparisons of the 
results obtained in different studies (regarding phytate degradation) are hampered by the influence of 
different methodologies. In particular, this influence hampers the complete understanding and 
comparisons with respect to the possible significance of inositols phosphorylated to different extents 
on the release and absorption of iron. 
10.1.2. Dialysability of Iron 
In vitro dialysability studies are useful in screening experiments when comparing iron absorption 
between different food items or meals, but a dialysis may exclude iron bound in large complexes that 
are bioavailable and on the other hand may include iron bound in smaller complexes (e.g., lower 
inositol phosphates and even phytate [85]) and yet are not bioavailable [86]. Argyri and co-workers 
found a good correlation between iron dialysability (particularly ferrous iron dialysability) and iron 
absorption in humans, indicating that ferrous iron dialysability can explain ~75% of the variation in  
in vivo absorption studies (67% explained by total dialyzable iron) [87]. Others report that dialysis 
studies usually, but not always, predict the right direction of the response (iron absorption) and that the 
magnitude of the response does not always correlate with what is found in human studies [88]. 
10.1.3. Caco-2 Cellular Iron Uptake 
Even though there are no substitutes for in vivo studies, Caco-2 cell models provide an alternative to 
expensive and time-consuming human studies [89] and it has been demonstrated that Caco-2 cells 
models can correctly predict the influence on iron bioavailability response of all key iron absorption 
modifiers [88]. In vitro model systems with Caco-2 cells are normally implemented with a two-phased 
simulated digestion mimicking the conditions in the stomach and the small intestine [90]. Often these 
Nutrients 2013, 5 3085 
 
simulations are run with a pH ~2 phase simulating the gastric ventricle and a pH ~7 phase simulating 
the small intestine. This model, however, has a risk of overestimating the phytate degradation due to 
the very low pH value in the stomach simulation. Studies have shown that pH in the stomach after a 
meal is in the range of ~3–7, meaning that phytate complexes will be less soluble in vivo than in the  
in vitro model, demonstrated by the finding that ~5% of phytate is soluble at pH 5.5 in simulated 
wheat gruel digesta compared to ~55%–70% at pH 2–4 [91]. The pH-dependence of solubility poses a 
potential bias of many in vitro studies, which should be kept in mind when evaluating results from 
these studies. 
Iron uptake in Caco-2 cells can be measured either as incorporation of radiolabelled iron or as an 
increase in ferritin in the cell, both of which have shown good correlation with iron absorption in 
humans from some in vivo studies on the effect of different dietary factors, whereas for other studies, 
no correlation has been found [88,90,92]. With regard to the influence of polyphenols and phytate on 
iron uptake, it has been reported that the sensitivity of Caco-2 cells models is similar to what is 
observed in human studies [88]. 
When compared to the dialysis evaluation, cellular uptake provides a better estimate of in vivo 
absorption, as dialysis only evaluates passive diffusion of iron, whereas in cell models, active cellular 
iron absorption is also taken into consideration [85]. It is also possible that the total fraction of 
dialysable iron is not available for cellular absorption [85], indicated, e.g., by a lack of proportionality 
between iron dialysability and Caco-2 cellular uptake in a study by Sanz-Penella et al., where it was 
explained by inhibitory concentrations of inositol hexa- and pentaphosphates [93]. Lynch concludes 
that the Caco-2 cell model may not accurately reflect the magnitude of the effects that influence iron 
absorption [48] and it should also be kept in mind that Caco-2 cell studies are often conducted with 
one layer of cells, thus having a significantly lower surface area available for absorption compared to 
the in vivo intestinal system [93]. 
10.2. Effect Evaluation Parameters in in Vivo Studies 
Iron bioavailability from foods is often evaluated by quantifying uptake of radio- or stable isotope 
labelled extrinsic iron that has been added to the food [89]. Otherwise, general iron status and iron 
absorption in in vivo studies can be evaluated using iron status indicators such as blood haemoglobin 
concentration, serum ferritin, transferrin receptors and/or iron concentration. Each of these has 
advantages and disadvantages: Haemoglobin concentration is a measure of anaemia and does not 
necessarily evaluate iron status, as iron deficiency and anaemia do not always occur concomitantly [94]. 
Also, normal haemoglobin ranges varies widely among individuals, making assessment of general iron 
deficiency difficult and they may also be affected by other factors such as malaria, malnutrition, age 
and pregnancy [95]. Serum ferritin has been shown to be a good indicator of body iron stores in 
healthy individuals, but is influenced by infections and acute or chronic inflammations [96]. 
Transferrin receptors are carrier proteins for transferrin and used as a marker of iron status. Transferrin 
receptors as an iron indicator has the advantage over serum ferritin that it is unaffected by 
inflammatory conditions [97]. Serum iron is linked to iron adequacy for development of red blood 
cells, but is not a good indicator of iron status due to diurnal and post-meal variations [94]. 
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10.3. Previous Studies on Phytases for Food Processing in Vitro and in Vivo 
10.3.1. Studies Evaluating Efficacy of in Vivo Phytase Catalysis 
Some of the earliest studies assessing the potential of enzymatic phytate degradation in vivo in 
humans were conducted by Sandberg and co-workers, who already in 1988, in a meal-study over two 
four day periods, showed that addition of extra endogenous wheat phytase in the form of bran 
increased phytate degradation in vivo compared with addition of phytase-deactivated bran [64]  
(Table 2). The potential of exogenous phytases for improving iron bioavailability was demonstrated by 
this group by assessing iron absorption from wheat rolls containing added fungal phytase  
(Aspergillus niger phytase). The iron absorption increased 83% from 14.3% to 26.1% [75] (Table 2).  
A more recent study has also shown that addition of A. niger phytase to cereal porridge can increase 
iron absorption 23%–70% (with a better effect on iron as FeSO4 compared to NaFeEDTA) or up to  
75% when added together with ascorbic acid [74] (Table 2). The study reported a total effect of 
ascorbic acid and phytase of ~400% increase in iron absorption from NaFeEDTA compared with iron 
absorption from FeSO4 given without absorption enhancers [74] (Table 2). This is in line with the 
consensus that ascorbic acid is a non-haem iron absorption enhancer [25]. 
All studies designed to boost in vivo phytate degradation via addition of A. niger phytase to a meal 
(with the enzyme added just prior to the ingestion, e.g., drizzled on top of bread or mixed into 
porridge) have shown that the phytase can act in vivo and generate a positive effect on iron 
bioavailability (Table 2). To our knowledge, no studies have documented the effect of in vivo phytate 
hydrolysis in humans catalysed by phytases from other organisms, but as discussed below, other 
phytases have been shown in vitro to potentially exhibit effects similar to the A. niger phytase. Iron 
absorption in response to phytase addition in the reported in vivo studies have ranged from 2.4% to 
26% and with iron intakes per meal ranging from ~2.5 to 8 mg. This increased iron absorption in effect 
results in absolute iron absorptions of up to ~0.5–1 mg per meal. Such an improvement infers that a 
cereal-based meal with phytase-enhanced iron absorption can produce a significant improvement with 
regard to the average requirements of 1–2 mg iron/day. 
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Table 2. Condensed results from in vivo phytase catalysis studies. Abbreviations:  
CA: citric acid; AA: ascorbic acid; AN: Aspergillus niger; M: male; F: female; C: children; 
ID: iron-deficient; NA: non-anaemic; SF: serum ferritin; Hb: haemoglobin;  
CRP: C-reactive protein; TfR: transferrin receptor; w/wo: with/without. 
Treatment 
Study design and 
duration 
Iron 
dosage 
Test group 
Evaluation 
parameter 
Result Reference 
Active or inactivated 
endogenous wheat bran 
phytase 
Meal study 
2 × 4 day periods 
n/a 
8 M, 1 F  
ileostomy patients  
(no information on 
iron status) 
Phytate 
degradation 
(Fe absorption  
not evaluated) 
↑ from ~5% with deactivated wheat 
bran phytase to ~60% with active 
wheat bran phytase 
[64] 
Active or inactivated 
endogenous wheat 
phytase or AN phytase 
2 separate meal 
studies with wheat 
rolls: (1) Active or 
inactivated wheat 
phytase; (2) Phytase-
inactivated wheat 
bran w/wo AN 
phytase 
3.7 mg 
labelled Fe 
+ 0.4 mg 
intrinsic 
Fe/meal 
9 M, 11 F split  
into 10 in each 
substudy  
(no information on 
iron status) 
Fe absorption 
(measurement of 
radiolabelled 
55
Fe/
59
Fe in  
blood samples) 
(1) No difference; (2) ↑ 83% from 
14.3% ± 2.6% to 26.1% ± 3.8% 
with AN phytase 
[75] 
Maize porridge taken 
with different 
micronutrient powders 
containing Fe  
(as NaFeEDTA or 
FeSO4) with AN 
phytase, AA,  
L-α-glycerophospho-
choline and/or Ca 
Meal study 
Crossover design  
(2 days) 
3 mg 
Fe/meal 
101 F (21 ID,  
1 ID anaemic) 
allocated to  
6 separate iron 
absorption studies  
(n = 16–18 in  
each substudy) 
Fe absorption 
(stable isotope 
labelled 
57
Fe/
58
Fe 
measurement in 
erythrocytes  
14 days later) 
Phytase: ↑ 23%–75% from  
2.4%–5.0% to 4.1%–7.4%. Highest 
effect of phytase was observed in 
combination with ascorbic acid, 
where total increase as result of 
phytase, ascorbic acid, and 
NaFeEDTA resulted in 400% 
absorption increase compared to 
iron absorption from FeSO4  
(1.5% to 7.4%). No significant 
effect of other single factors 
[74] 
High-phytate porridge 
taken with 
micronutrient powder 
containing Zn, Fe as 
NaFeEDTA, AA and 
AN phytase 
Diet study 
(5 days/week for  
23 weeks) 
Double-blind 
controlled study 
Control: No Fe 
supplement 
2.5 mg 
Fe/meal 
200 C 
(low iron status) 
Fe status 
(SF, Hb, CRP, 
TfR content in 
blood samples) 
Occurrence of Fe deficiency ↓ 75% 
(↓ 35% in control group) 
Body Fe ↑ 100% (↑ 40% in control) 
Fe absorption ~7%–8% 
[98] 
Fe-rich bread w/wo 
phytase supplement 
compared with  
FeSO4 supplement 
Meal study 
5–8 mg 
Fe/meal 
24 F (borderline 
anaemic) allocated to  
5 test meals 
Fe status (serum 
iron measured  
180 and 210 min  
after ingestion) 
Serum Fe ↓ in all groups at 180 and 
210 min after intake except for the 
positive control group given  
FeSO4 supplement. 
Decrease in serum Fe was largest in 
the order of iron-rich bread > 
control bread > iron-rich bread with 
0.010% (w/w) phytase > iron-rich 
bread with 0.015% (w/w) phytase 
[99] 
Nutrients 2013, 5 3088 
 
One research group observed a decline in serum iron after the study subjects had ingested the  
iron-rich meals [99]. Such a decline was also observed in a study conducted by Conway et al. [100], 
where the serum iron decline correlated with high amounts of phytate in the ingested meal. However, 
phytase diminished the serum iron decline compared to the control meal in the study by  
Bokhari et al. [99], indicating that high phytate intake could explain the decrease in serum iron levels, 
although in this latter study, the phytate content was unfortunately not reported. One study did not 
include a control group that received the meal with iron supplement, but without added phytase 
(although they did have a control group receiving a meal without any iron supplement), making it 
difficult to single out the added effect of the phytase on the iron absorption [98]. 
The available studies are obviously quite different with regard to design of study, target group, 
compositions of the meals or whole diets, especially with regard to the content of phytase and 
phytate:iron ratio, making any firm conclusions difficult. However, overall, the available data suggest 
that A. niger phytase may have the potential to improve in vivo iron absorption in humans. 
10.3.2. Studies Evaluating Efficacy of ex Vivo Phytase Catalysis on in Vivo Parameters 
Effect of phytase-mediated pretreatment of cereal-based foods has been documented as increases in 
in vivo iron absorption from 78% up to as much as 1066% in single meal studies [12,101] (Table 3). 
However, a four-month intervention study with 41 women did not show an effect of phytase 
pretreatment [5] (Table 3). This was probably due to the low degree of phytate dephosphorylation  
(~22%) achieved with the enzyme treatment in this study, which was not enough to release iron from 
the phytate complexes (InsP5+6:Fe ratio was ~0.6 in the phytase-treated bread). 
10.3.3. Studies Evaluating Efficacy of ex Vivo Phytase Catalysis on in Vitro Parameters 
In vitro studies have shown that A. niger phytase has the potential to degrade phytate and thereby 
improve potential for iron absorption during in vitro digestion or as a pretreatment step for foods prior 
to ingestion (Table 4). One study found phytate degradation in bread with A. niger phytase to be up to 
97%, resulting in an increased cellular iron uptake by Caco-2 cells of ~150% [102]. Similar results 
were obtained by Sanz-Penella et al. [93] (~97% InsP5+6 degradation, 92% increase in iron uptake by 
Caco-2 cells) (Table 4). 
Whereas reasonable correlation was seen between Caco-2 cell iron uptake and phytate degradation, 
the correlation between phytate degradation and dialysability is unclear, see e.g., Sanz-Penella et al. [103] 
and Akhter et al. [104], who find very different correlations between phytate degradation and iron 
dialysability (Table 4). This indicates that inositol phosphates (and especially lower inositol phosphates) 
can be dialysed, but are not available for cell uptake. The finding that iron uptake by Caco-2 cells only 
increase after extensive phytate degradation, i.e., in the order of >90% degradation, also underlines that 
phytate degradation needs to be virtually complete and phytate:iron ratios should be low for iron 
absorption to increase [34,57]. One group has also shown potential of other microbial phytases (E. coli, 
A. fumigatus) for phytate degradation [21] (Table 4). 
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Table 3. Condensed results from studies employing ex vivo phytase catalysis evaluated on 
in vivo parameters. Abbreviations: CA: citric acid; AN: Aspergillus niger; M: male;  
F: female; C: children; ID: iron deficient; NA: non-anaemic; SF: serum ferritin;  
InsP6: phytate; InsP3: myo-inositol triphosphate. 
Treatment 
Study design 
and duration 
Iron 
dosage 
Test group 
Evaluation 
parameter 
Result Reference 
AN phytase addition 
to cereal porridges 
during manufacturing 
Meal study 
2.5 mg 
Fe/meal 
34 M (1 ID), 
44 F (13 ID), 
all NA 
Fe absorption 
(measurement of 
radiolabel-led 
55
Fe/
59
Fe in  
blood samples) 
↑ 209%–1066% from 0.3% to 
2.4%→2.8%–11.5% 
[105] 
AN phytase added 
during making of  
fibre-rich wheat bread 
Intervention 
study; 4 months 
6 mg 
Fe/meal,  
14 mg/day 
41 iron-
sufficient F 
Fe absorption  
in vivo (SF) 
InsP3-6 content  
in bread 
No effect on SF by phytase 
treatment; InsP5+6 contents  
↓ 17%; InsP3-6 content ↓ 22% 
[5] 
CA and AN phytase 
addition to oat 
beverage as 
pretreatment 
Meal study,  
4 days 
1.3 mg 
Fe/meal 
23 M, 22 F 
(non-ID) 
Fe absorption  
in vivo (radio-
labelled 
55
Fe/
59
Fe 
count in whole 
body and  
eryth-rocytes); 
InsP3-6 content in 
oat beverage 
CA: ↑54% (from 3.9% to 6.0%) 
Phytase added with CA further 
increased iron absorption by 78% 
(6.0%→10.7%);  
Phytase reduced InsP3-6 to 
undetectable amounts  
(<1 mg/portion), phytate-P ↓ 83% 
[101] 
Table 4. Condensed results from studies employing ex vivo phytase catalysis evaluated on 
in vitro parameters. Abbreviations: CA: citric acid; AA: ascorbic acid; AN: Aspergillus 
niger; InsP: myo-inositol phosphate; InsP6: phytate; InsP5: myo-inositol pentaphosphate;  
InsP3: myo-inositol triphosphate; w/wo: with/without. 
Treatment Evaluation parameter Result Reference 
Addition of AN,  
A. fumigatus or E. coli 
phytase w/wo CA and AA to 
whole-wheat bread dough 
Phytate 
1
 degradation 
Fe dialysability from bread 
CA: Phytate degradation ↑ from 42% in control to 69%;  
Fe dialysability ↑ 12-fold 
AN phytase alone: Phytate degradation 57%, no significant effect 
on dialysability 
Microbial phytases + CA:  
AN: Phytate degradation 74%–85% (dose-dependent);  
Fe dialysability ↑ 15-fold. 
E. coli: Phytate degradation 63%–76% (dose-dependent);  
Fe dialysability not assessed 
A. fumigatus: Phytate degradation 83%–85% (dose-dependent);  
Fe dialysability not assessed 
AN phytase + CA + AA: Fe dialysability ↑ 24-fold compared  
to control 
[21] 
AN phytase addition during 
making of different bread 
Phytate 
1
 degradation Phytate degradation ↑ 12%–57% compared to control depending on 
bread type, total phytate degradation with phytase: 49%–90% 
[106] 
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Table 4. Cont. 
High-phytase producing 
yeast strains addition during 
in vitro digestion of  
wheat gruel 
Phytate degradation ≤59% 
[91] 
Bifidobacteria cell 
suspensions or AN phytase 
addition during  
wheat bread making 
InsP3-6 content in bread Phytase: each InsP ↓ 67%–100% (mean ± standard deviation  
91% ± 10%) compared to control;  
Bifidobacteria: each ↓ −8%–67% (19% ± 27%) compared  
to control 
[107] 
Highly phytase-producing 
yeasts (experimental strains), 
S. cerevisiae or A. ficuum 
phytase addition to togwa 
prior to ingestion  
Phytate degradation after 
48 h fermentation 
S. cerevisiae: 85%  
A. ficuum phytase: 89% 
Experimental strains: 95% 
Control: 51% 
[108] 
Activating endogenous 
phytase in fortified and  
non-fortified  
flour/oilseed mixtures 
Fe dialysability Wheat/soy: ↑ 43%–162% (non-fortified); ↑ 40%–168% (fortified); 
Wheat/groundnut: ↑ 83%–192% (non-fortified);  
97%–240% (fortified) 
Dialysable Fe in controls: 1.3%–9.7% 
[109] 
AN phytase addition during 
in vitro digestion of bread 
Phytate degradation 
Fe bioavailability in  
Caco-2 cell model 
Phytate degradation 89%–97% 
Cellular uptake of Fe ↑ 152%–156%  [102] 
Fungal phytase or phytase-
producing bifidobacteria 
addition during whole wheat 
bread- or whole wheat 
sourbread-making 
InsP5 + InsP6 degradation 
Fe dialysability 
Ferritin formation in  
Caco-2 cells 
Whole wheat bread: 
Fungal phytase: InsP5+6 degradation ~97%; dialysable Fe ↑ 17%, 
dialysability ↓ 9%; Caco-2 cell uptake ↑ 92% 
Bifidobacteria: InsP5+6 degradation ~76%; dialysable Fe ↑ 127%, 
dialysability ↑ 118%; Caco-2 cell uptake ↑ 33% (not significant) 
Whole wheat sourbread: 
Fungal phytase: InsP5+6 degradation ~68%; dialysable Fe ↑ 45%, 
dialysability ↑ 82%; Caco-2 cell uptake ↑ 67% (not significant) 
Bifidobacteria: InsP5+6 degradation of ~58%–70%; dialysable Fe 
↑ 283%–456%; dialysability ↑ 236%–391%; Caco-2 cell uptake ↑ 
0%–25% (not significant) 
[93] 
A. oryzae phytase or 
phytase-producing 
bifidobacteria addition 
during pretreatment of  
infant cereals 
Phytate degradation 
Fe dialysability 
A. oryzae phytase: 
InsP6 ↓ 45%–67% compared to control; InsP3-6 (total)  
↓ 25%–28%; no change in Fe dialysability 
Bifidobacteria: 
InsP6 ↓ 75%–87% compared to control; InsP3-6 (total)  
↓ 23%–63%; no change in Fe dialysability 
[103] 
Exogenous wheat phytase 
addition to wheat flour 
Phytate 
1
 degradation 
Fe dialysability 
Phytate ↓ 35%–69% 
Fe dialysability ↑ 11%–52% (from 12% to 16% to 15%–25%)  
[104] 
1
 The term phytate has here been used to cover the higher inositol phosphates (as determined by Wade reagent or precipitation).  
11. Other Options for Enhancing Iron Absorption 
Other options for enhancing iron bioavailability from meals and/or whole diets have been reviewed 
extensively elsewhere (e.g., [3,34,110]) and includes the pretreatment of grains, e.g., soaking, malting 
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and germination, as well as addition of organic acids, in particular ascorbic acid and citric acid, and 
various other complexing agents in order to minimise the inhibitory effect of phytate on iron absorption. 
Clearly, some of the classical pretreatments such as soaking, malting and germination in fact serve 
to activate the endogenous cereal phytases, and in turn become phytase-mediated approaches. 
Several approaches involving genetically modified crops, either with low phytate content or higher 
phytase activity, have also been considered [2], but these strategies have not yet gained ground. 
Finally, direct fortification of foods and separate iron supplementation are of course still potential 
solutions to improve the iron status of vulnerable populations. As already discussed above, iron 
supplementation may work in combination with phytase-mediated degradation of phytate for 
improving iron absorption from phytate-rich meals. 
12. Conclusions 
Several studies indicate that microbial phytase ingested with a phytate-rich meal (with the phytase 
added to the food) or added as a pretreatment aid has potential for increasing iron absorption from 
single foods. The action mechanism is enzymatic phytate degradation, which—if virtually complete—
will result in release of chelated iron. It seems favourable to include citric and/or ascorbic acid in 
meals as these have been shown convincingly to act synergistically with the phytases in increasing  
iron absorption. The improved iron absorption potentially improves iron status in particularly  
iron-deficient individuals. 
To our knowledge, only the A. niger phytase enzyme has been used in in vivo studies. It is therefore 
tempting to conclude that this particular enzyme is particularly effective in improving iron absorption 
via phytase degradation, but in vitro studies have suggested that other phytases can also effectively 
catalyse the degradation of phytate under physiologically relevant conditions. Fungal phytases have 
higher thermal stability than bacterial phytases, but the currently available data suggests that bacterial 
phytases, e.g., E. coli phytase, may also have potential due to an apparently higher proteolytic 
resistance against pepsin compared with the A. niger phytase, which in turn is more stable than the 
wheat phytase. Options for improving phytase stability in the gut should be investigated, including 
genetic engineering and/or formulation approaches. There are no substitutes for in vivo studies, but 
Caco-2 cell uptake studies have given good pre-clinical results and may provide a means to better 
unravel the detailed mechanisms of cellular iron receptor activation, compare iron bioavailability from 
different foods as well as deduce any correlations between phytase action rates for degradation of 
phytate, iron release, and cellular absorption rates. In any case, to improve our quantitative 
understanding the research must emphasise analysis and reporting of remaining inositol phosphate 
contents as well as phytate:iron ratios in the final digesta/pretreated food, since these parameters are 
crucial for determining iron absorption in vivo. 
Further research on the exact chemical form of iron and phytate in the stomach and especially the 
possibility of cellular uptake from iron loosely chelated to lower inositol phosphates is needed in order 
to elucidate further the potential and mechanism of phytase-mediated iron release and absorption in the 
human body. In relation to this, a better understanding of the affinity of phytases towards soluble and 
insoluble iron phytate complexes present in phytate globoids is warranted. A deeper understanding of 
the significance of phytase dosage, kinetics (i.e., rates of dephosphorylation), and stability under 
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gastrointestinal conditions would aid in identifying key focus points with regard to design of intelligent 
solutions for in vivo phytase catalysis. These issues are crucial for defining the efficacy of  
phytase-mediated iron release, as the time window for in vivo catalysis will be limited by both enzyme 
stability and gastrointestinal transit times. With more knowledge on these issues, engineering of better 
dietary solutions for improved iron absorption from cereal and other plant foods would be possible. 
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